DENTON INDUSTRIES, INC. – Trademark Portfolio

Entity Type: 03

DENTON INDUSTRIES, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ZONE and ALGINATOR. The owner is based in LOS ANGELES, CA.

SELBY AVE.

LOS ANGELES, CA 90034

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

DENTON INDUSTRIES, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does DENTON INDUSTRIES, INC. have?

DENTON INDUSTRIES, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 2 registered, 4 cancelled.

What trademark classes does DENTON INDUSTRIES, INC. file in?

DENTON INDUSTRIES, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are DENTON INDUSTRIES, INC.'s most well-known trademarks?

DENTON INDUSTRIES, INC.'s registered trademark portfolio includes well-known marks such as ZONE and ALGINATOR. These are among 2 currently registered trademarks in the portfolio.

What is DENTON INDUSTRIES, INC.'s trademark registration success rate?

DENTON INDUSTRIES, INC. has a 33% trademark registration rate, with 2 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.